Intellia Therapeutics, Inc. · 1 day ago
Associate Scientist, Molecular and Cell Biology
Cambridge, MA
Full-time
Onsite
Mid Level
$104K/yr - $126K/yr
4+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Associate Scientist will be part of the sgRNA screening team, responsible for testing sgRNAs, developing assays, and collaborating with various groups to advance genome editing projects.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Isolate, culture and/or bank primary cells and/or immortalized cell lines
Transfect, transduce and/or electroporate cultured cells with genome editing reagents
Develop, optimize and execute routine cell viability, mRNA and protein expression assays
Quantify on- and off-target genome editing outcomes using various methods such as amplicon sequencing and ddPCR
Work with team leads to ensure project timelines are met
Record data in an electronic lab notebook and assist in intellectual property fillings
Interpret findings and provide input to various projects
Present updates in team meetings
Qualification
Required
Excellent verbal and written communication skills
Excellent interpersonal skills
Excellent organizational skills and attention to detail
Excellent time management skills with a proven ability to meet deadlines
Strong analytical and problem-solving skills
Ability to function well in a high-paced environment
BS or MSc degree in Biology or related disciplines
BS or MSc degree in Biology or related disciplines with 4+ years (BS degree) or 2+ years (MS degree) of industry experience is required
Extensive experience with cell culture and molecular biology assays is required
Preferred
Experience with primary hepatocytes and/or primary hematopoietic stem and progenitor cells is strongly preferred
Hands-on experience with Illumina library construction, quantification, sequencing, and data QC is preferred
Experience with liquid handling automation systems is preferred
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
2025-12-29
EIN Presswire
2025-11-26
Company data provided by crunchbase